Authors
Rebecca Khan, MD, FACOG, practiced obstetrics and gynecology for 21 years before serving as the director of women’s health for BioReference® Laboratories, LLC. Currently, Khan works in medical affairs at Thermo Fisher Scientific with a focus on placental biomarkers, sFlt-1 and PlGF.
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
2
What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO
3
ACA Enrollment Erosion Deepens After Open Enrollment Ends
4
Efgartigimod Effective in Broad Subsets of Patients With gMG
5

